The effects of parathyroid hormone fragments on bone formation and their lack of effects on the initiation of colon carcinogenesis in rats as indicated by preneoplastic aberrant crypt formation

Cancer Letters

Volumn 200, Issue 2, 2003, Pages 107-113

  Whitfield, James ^a   Bird, Ranjana P ^b   Morley, Paul ^c   Willick, Gordon E ^a   Barbier, Jean René ^a   MacLean, Susanne ^a   Ross, Virginia ^a  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c Zelos Therapeutics Inc   (Canada)

Author keywords

Aberrant crypt; Bone formation; Carcinogenesis; Colon; Parathyroid hormone

Indexed keywords

AZOXYMETHANE; CARCINOGEN; PARATHYROID HORMONE; PARATHYROID HORMONE DERIVATIVE; PARATHYROID HORMONE[1-31][27 LEUCINE]CYCLO[22 GLUTAMIC ACID 26 LYSINE]AMIDE; PARATHYROID HORMONE[1-34]; UNCLASSIFIED DRUG; PEPTIDE FRAGMENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CARCINOGEN TESTING; CHEMICAL CARCINOGENESIS; COLON; COLON CARCINOGENESIS; COLON CARCINOMA; CONTROLLED STUDY; DRUG EFFECT; DRUG EXPOSURE; FEMALE; INTESTINE CRYPT; NONHUMAN; OSSIFICATION; PRECANCER; PRIORITY JOURNAL; RAT; STIMULATION; TISSUE DISTRIBUTION; ANIMAL; BONE DEVELOPMENT; CHEMICALLY INDUCED DISORDER; COLON TUMOR; SPRAGUE DAWLEY RAT;

ANIMALIA;

ANIMALS; AZOXYMETHANE; CARCINOGENS; COLONIC NEOPLASMS; OSTEOGENESIS; PARATHYROID HORMONE; PEPTIDE FRAGMENTS; PRECANCEROUS CONDITIONS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0642335057     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(03)00162-9     Document Type: Article

References (29)

1. Whitfield J.F., Morley P., Willick G.E. The Parathyroid Hormone: An Unexpected Bone Builder for Treating Osteoporosis. 1998;R.G. Landes Company, Austin.
2. Whitfield J.F., Morley P., Willick G.E. Parathyroid hormone, its fragments and their analogs for the treatment of osteoporosis. Treat Endocrinol. 1:2002;175-190.
3. Vahle J.L., Sato M., Long G.G., et al. Skeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone (1-34) for 2 years and relevance to human safety. Toxicol Pathol. 30:2002;312-321.
4. Betancourt M., Wirfel K.L., Raymond A.K., Yasko A.W., Lee J., Vassilopoulou-Sellin R. Osteosarcoma of bone in a patient with primary hyperparathyroidism: a case report. J Bone Miner Res. 18:2003;163-166.
5. Smith J., Huvos A.G., Chapman M., Rabbs C., Spiro R.H. Hyperparathyroidism associated with sarcoma of bone. Skeletal Radiol. 26:1997;107-112.
6. Wiig J.N., Sand T. Bakker. Acta Chir Scand. 137:1971;391-393.
7. Li H., Seitz P.K., Thomas M.L., Selvanayagam P., Rajaraman C., Cooper C.W. Widespread expression of the parathyroid hormone-related peptide and PTH/PTHrP receptor genes in intestinal epithelial cells. Lab Invest. 73:1995;864-8704.
8. 2+. Biochim Biophys Acta. 1540:2001;201-212.
9. Gentili C., Morelli S., Russo-deBoland A. Involvement of PI3-kinase and its association with c-Src in PTH-stimulated rat enterocytes. J Cell Biochem. 86:2002;773-783.
10. Artru P., Tournigand C., Mabro M., Lucchi E., Louvet C., DeGramont A., Krulik M. Hyperparathyrodie primitive associe au cancer colique. Gastroenterol Clin Biol. 25:2001;208-209.
11. Conteas C.N., Desai T., Arlow F.A. Relationship of hormones and growth factors to colon cancer. Gastroenterol. Clin. N. Am. 17:1988;761-772.
12. Farr H.W. Hyperparathyroidism and cancer. CA Cancer J Clin. 26:1976;66-74.
13. Feig D.S., Gottesman I.S. Familial hyperparathyroidism in association with colonic carcinoma. Cancer. 60:1987;429-432.
14. Kawamura Y.J., Kazama S., Miyahara T., Masaki T., Muto T. Sigmoid colon cancer associated with primary hyperparathyroidism: report of a case. Surg Today. 29:1999;789-790.
15. Strodel W.E., Thompson N.W., Eckhauser F.E., Knol J.A. Malignancy and concomitant primary hyperparathyroidism. J. Surg. Oncol. 37:1988;10-12.
16. Bird R.P. Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett. 93:1995;55-71.
17. Bird R.P., Good C.K. The significance of aberrant crypt foci in understanding the pathogenesis of colon cancer. Toxicol Lett. 112-113:2000;395-402.
18. Rodrigues M.A., Silva L.A., Salvadori D.M.F., deCamargo J.L.V., Montenegro M.R. Aberrant crypt foci and colon cancer: comparison between a short- and medium-term bioassay for colon carcinogenesis us dimethylhydrazine in Wistar rats. Brazil J Med Biol Res. 35:2002;351-355.
19. 2 to stimulate bone growth in ovariectomized rats. J Bone Miner Res. 12:1997;1246-1252.
20. Whitfield J.F., Chakravarthy B. Calcium: The Grand-Master Cell Signaler. 2001;NRC Press, Ottawa.
21. Aubin J.E., Triffitt J.E. Mesenchymal stem cells and osteoblast differentiation. Bilezekian J.P., Raisz L.G., Rodan G.A. Principals of Bone Biology. Vol. 1:2002;59-91 Academic Press, San Diego, CA.
22. Alliston T.N., Derynck R. Transforming growth factor-( in skeletal development and maintenance). Canalis E. Skeletal Growth Factors. 2000;233-249 Lippincott Williams & Wilkins, Philadelphia, PA.
23. Hurley M.M., Tetradis S., Huang Y.F., Hock J., Kream B., Raisz L.G., et al. Parathyroid hormone regulates the expression of fibroblast growth factor-2 mRNA and fibroblast growth factor receptor mRNA in osteoblastic cells. J Bone Miner Res. 14:1999;776-783.
24. Pfeilschrifter J., Laukhuf F., Muller-Beckmann B., Blum W.F., Pfister T., Ziegler R. Parathyroid hormone increases the concentration of insulin-like growth rfactor-I and transforming growth factor beta 1 in rat bone. J Clin Invest. 96:1995;767-774.
25. Stork P.J.S., Schmitt J.M. Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation. Trends Cell Biol. 12:2002;258-266.
26. Fujita T., Meguro T., Fukuyama R., Nakamuta H., Koida M. New signaling pathway for parathyroid hormone and cyclic AMP action on extracellular- regulated kinase and cell proliferation in bone cells: checkpoint of modulation by cyclic AMP. J Biol Chem. 277:2002;22191-22200.
27. deRooij J., Rehmann H., van Triest M., Cool R.H., Wittinghofer A., Bos J.L. Mechanism of regulation of the Epac family of cAMP-dependent RapGEFs. J Biol Chem. 275:2000;20829-20836.
28. Zwartkruis F.J.T., Bos F. Ras and Rap 1: two highly related small GTPases with distinct functions. Exp Cell Res. 253:1999;157-165.
29. Greaves M. Cancer: The Evolutionary Legacy. 2000;Oxford University Press, Oxford.